Search
Tonix Pharmaceuticals Holding Corp
TNXPAdd to Watchlist
11.870USD
-0.410-3.34%
Close 09-11 16:00（ET）
198.99MMarket Cap
LossP/E TTM
Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Tonix Pharmaceuticals Holding Corp in the past month.
Buy
1 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
42.400USD+230.48%
TNXP Analyst Recommendation Trends
In the current month, TNXP has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TNXP average Analyst price target in the last month is 42.400.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
0
0
0
0
0
3
3
3
3
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
3
2
2
2
2
TNXP Analyst Rating for Peer Comparison
Updated: Sep 11, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, TNXP EPS is projected to reach -2.463 in FY2026Q3, following reported EPS of -2.438 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-3.19
-2.43
-2.70
-2.46
-2.42
Actual
-3.96
-2.93
-2.44
--
--
Surprise
-24.25%
-20.51%
+9.60%
--
--
FAQs
What is Tonix Pharmaceuticals Holding Corp's expected revenue for the next quarter?
Tonix Pharmaceuticals Holding Corp's expected revenue is 12.72M.
What is Tonix Pharmaceuticals Holding Corp's price target?
Analysts forecast that Tonix Pharmaceuticals Holding Corp's price target is USD 42.40, with the highest forecast at USD 65.00 and the lowest forecast at USD 22.00.
How have Tonix Pharmaceuticals Holding CorpTNXP's recent earnings per share performed?
The market expectation was USD -2.44, while Tonix Pharmaceuticals Holding CorpTNXP's earnings per share (EPS) for the previous quarter was USD -2.93. EPS for the next quarter is expected at USD -2.46.
What is the analyst rating for Tonix Pharmaceuticals Holding Corp?
Based on the ratings of Tonix Pharmaceuticals Holding Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.